HERMAB 150MG

What is HERMAB 150MG?

HERMAB 150MG is a prescription anticancer medication that contains Trastuzumab as its active ingredient. It is a monoclonal antibody used in the treatment of certain types of breast and stomach (gastric) cancers. Trastuzumab works by targeting and blocking the HER2 (Human Epidermal Growth Factor Receptor 2) protein, which is responsible for the growth of cancer cells in some patients.

---

What is the use of HERMAB 150MG?

HERMAB 150MG is primarily used in the treatment of:

• HER2-positive breast cancer (both early-stage and metastatic)

• HER2-positive gastric (stomach) or gastroesophageal junction cancer

It may be used alone or in combination with chemotherapy drugs depending on the cancer type and stage. The medicine helps in slowing down or stopping the growth of cancer cells that overexpress the HER2 receptor.

---

Benefits of HERMAB 150MG

• Targeted cancer therapy: Specifically attacks HER2-positive cancer cells without affecting normal cells.

• Improved survival rate: Increases the chances of recovery and reduces cancer progression.

• Used for multiple cancers: Effective against both breast and stomach cancers with HER2 overexpression.

• Can be used in combination therapy: Works well with chemotherapy for better outcomes.

• Well-studied and trusted formulation: Clinically proven monoclonal antibody therapy widely used globally.

---

Side Effects of HERMAB 150MG

While HERMAB 150MG is effective, some patients may experience side effects such as:

• Fever, chills, or headache after infusion

• Nausea or vomiting

• Diarrhea

• Weakness or fatigue

• Cough or breathing difficulty

• Rash or allergic reaction at the injection site

• Heart-related issues (rare but serious) — regular monitoring is recommended

Always consult your oncologist before starting or stopping HERMAB 150MG, and follow the prescribed dosage and treatment schedule carefully.

---

Precautions and Safety Advice

• Should only be administered under the supervision of a qualified oncologist.

• Inform your doctor if you have a history of heart disease or breathing problems.

• Regular heart function tests (like ECG or echocardiogram) may be required.

• Avoid pregnancy during treatment and for at least 7 months after the last dose.

• Not recommended for patients allergic to Trastuzumab or other monoclonal antibodies.

1. What is HERMAB 150MG used for?
HERMAB 150MG is used to treat HER2-positive breast cancer and HER2-positive gastric (stomach) cancer. It works by targeting and blocking the HER2 protein that helps cancer cells grow.

---

2. What is the active ingredient in HERMAB 150MG?
The active ingredient in HERMAB 150MG is Trastuzumab, a monoclonal antibody designed to attack HER2-positive cancer cells.

---

3. How does HERMAB 150MG work?
HERMAB 150MG binds to the HER2 receptors on cancer cells and prevents them from receiving growth signals, which helps slow or stop the spread of the cancer.

---

4. How is HERMAB 150MG administered?
It is given as an intravenous (IV) infusion by a healthcare professional in a hospital or oncology center.

---

5. Can HERMAB 150MG be used alone?
Yes. HERMAB 150MG can be used alone or in combination with chemotherapy, depending on the type and stage of cancer.

---

6. What are the common side effects of HERMAB 150MG?
Common side effects include fever, chills, weakness, nausea, diarrhea, cough, rash, and fatigue. Some patients may also experience mild injection site reactions.

---

7. Are there any serious side effects of HERMAB 150MG?
Yes, serious side effects may include heart problems, allergic reactions, or breathing difficulties. Regular heart monitoring is essential during treatment.

---

8. How often is HERMAB 150MG given?
The dosing schedule depends on your treatment plan. It is usually given once every week or once every three weeks, as directed by your oncologist.

---

9. Can pregnant women use HERMAB 150MG?
No. HERMAB 150MG should not be used during pregnancy as it may harm the unborn baby. Effective contraception must be used during treatment and for at least 7 months after the last dose.

---

10. Is HERMAB 150MG a form of chemotherapy?
No. HERMAB 150MG is not a traditional chemotherapy drug. It is a targeted therapy that attacks specific cancer cells without harming normal cells as much as chemotherapy does.

---

11. How long does treatment with HERMAB 150MG last?
Treatment duration varies based on the patient’s condition. It may last several months to a year, depending on the response to therapy.

---

12. Can HERMAB 150MG cause hair loss?
HERMAB 150MG alone usually does not cause hair loss, but when used with chemotherapy, hair loss may occur due to the chemotherapy drugs.

---

13. What should I do if I miss a dose of HERMAB 150MG?
Inform your doctor immediately. Your oncologist will reschedule the missed infusion to maintain proper treatment intervals.

---

14. Can I take other medicines while on HERMAB 150MG treatment?
Always inform your doctor about all other medications, supplements, or herbal products you are taking, as they may interact with Trastuzumab or affect your treatment.

---

15. How should HERMAB 150MG be stored?
Store the vial in a refrigerator between 2°C and 8°C. Do not freeze or shake the vial. Keep it out of reach of children and use it before the expiry date.